Author - ISN admin

Reducing Clotting in Patients with COVID-19

Watch to the talk on Academy Andrew Allegretti, MD MSc Director of Critical Care Nephrology, Division of Nephrology, Massachusetts General Hospital Assistant Professor of Medicine, Harvard Medical School Ignacio: Good morning and welcome to our series of interviews from the International Society of Nephrology with experts and authors of articles relevant to nephrology and COVID 19. My...

Acute PD during COVID-19 experience in an academic medical center in New York.

Watch to the talk on Academy This interview has been redacted for clarity and brevity. Ladan Golestaneh, M.D., M.S. Professor, Department of Medicine (Nephrology) Albert Einstein College of Medicine Ignacio P: Welcome to this ISN meeting, podcasts and interviews. My name is Ignacio and one of the second-year nephrology fellows at Brigham and Women’s Hospital and Mass General...

Joint Statement from ASN, ERA, and ISN Addresses the State of the Global Nephrology Workforce

Chronic kidney disease (CKD) is a global health crisis with an estimated 850 million affected individuals. The State of the Global Nephrology Workforce: A Joint ASN-ERA-EDTA-ISN Investigation addresses whether there are enough kidney doctors-or nephrologists available to care for the growing number of people around the world with CKD, and whether their training is...

ISN responds to WHO consultation on recommendations to strengthen and monitor diabetes responses

The International Society of Nephrology (ISN) welcomes the opportunity to provide feedback on the WHO Discussion Paper: Draft recommendations to strengthen and monitor diabetes responses within national noncommunicable disease programmes, including potential targets and on the document Improving Health Outcomes of People with Diabetes Mellitus: Target Setting to Reduce the Global Burden of Diabetes...

Global Kidney Care Podcast: Advocacy Edition Part 1 – A Beginners’ Guide to Kidney Health

It’s shocking that although between 8 and 10% of the adult population live with some form of kidney damage, and millions die prematurely each year from complications related to kidney disease, “kidneys do not appear to be considered by the public as vital organs that need to be considered and kept healthy.” To address this...

eDigest – Summary Highlights

~ Vivekanand Jha The COVID-19 pandemic continues to wreak havoc in many parts of the world. While some countries seem to have this in their rear view mirror, others are still struggling to manage the repeated surges. The unique predicament of patients with kidney disease during the pandemic, especially those on dialysis and kidney transplant...

Congratulations to the Recipients of the ISN 2021 Awards

The ISN is pleased to announce this year’s recipients of the: Alfred Newton Richards Award Roscoe R. Robinson Award Lillian Jean Kaplan International Prize for Advancement in the Understanding of Polycystic Kidney Disease ISN Pioneer Awards The 2021 winners are honored for their commitment to nephrology. Award winners will be recognized at The ISN World Congress of Nephrology 2021,...

Narrative-based Clinical Trials (ISN-ACT) Toolkit

To illustrate important clinical trial methodologies, Augusto Cesar Soares dos Santos and Brendan Smyth, ISN-ACT Clinical Trials Toolkit subgroup members, are developing a series of stories based on various toolkit topics. The first of these narratives outlines trial randomization methods through a fictional clinical discussion. Access chapter one

The Pragmatic #Nephtrials Wrapup

A joint initiative from NephJC and the International Society of Nephrology, #NephTrials is the newest initiative in #NephTwitter. It is a tweetchat aimed at increasing awareness about ongoing trials in nephrology, and to inform the wider nephrology community about what nephrology trialists consider when designing and conducting trials. The hope is that this will...